FG Stock Analysis: F&G Annuities & Life | NYSE
Insurance - Life | NYSE, USA | Market Cap: 2.562m USD | 12M Return: -29% | US30190A1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 14.1M
EPS Trend: 58.5%
Qual. Beats: 0
Rev. Trend: 78.7%
Qual. Beats: 4
Warnings
Tailwinds
No distinct edge detected
Seasonality 3.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
F&G Annuities & Life, Inc. is a U.S.-based provider of annuity and life insurance products, serving both retail and institutional customers. Its product portfolio spans fixed indexed annuities, registered index-linked annuities, multi-year guarantee annuities, immediate annuities, indexed universal life insurance, pension risk transfer solutions, and institutional funding agreements. The company distributes these offerings through independent agents, banks, and broker-dealers, and was founded in 1959 and is headquartered in Des Moines, Iowa. F&G operates as a subsidiary of Fidelity National Financial, Inc.
As a life and health insurance issuer, F&G generates revenue primarily through premium income, fees on annuity contracts, and investment returns on the assets backing its policyholder reserves. The pension risk transfer segment, in which insurers assume defined benefit plan obligations from corporate sponsors, has grown as more companies seek to offload longevity and investment risk from their balance sheets.
- Pension risk transfer premiums accelerate with institutional de-risking
- Net investment spread expands as long-term rates rise
- Registered index-linked annuity sales drive retail growth
| Net Income: 418.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.97 > 1.0 |
| NWC/Revenue: -269.2% < 20% (prev 632.1%; Δ -901.3% < -1%) |
| CFO/TA 0.05 > 3% & CFO 4.70b > Net Income 418.0m |
| Net Debt (-398.0m) to EBITDA (1.39b): -0.29 < 3 |
| Current Ratio: 0.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (130.0m) vs 12m ago -2.99% < -2% |
| Gross Margin: 31.74% > 18% (prev 29.06%; Δ 2.68% > 0.5%) |
| Asset Turnover: 6.12% > 50% (prev 5.43%; Δ 0.68% > 0%) |
| Interest Coverage Ratio: 4.16 > 6 (EBIT TTM 686.0m / Interest Expense TTM 165.0m) |
| A: -0.16 (Total Current Assets 2.65b - Total Current Liabilities 18.7b) / Total Assets 104b |
| B: 0.03 (Retained Earnings 2.67b / Total Assets 104b) |
| C: 0.01 (EBIT TTM 686.0m / Avg Total Assets 97.7b) |
| D: 0.05 (Book Value of Equity 4.61b / Total Liabilities 98.9b) |
| Altman-Z'' = -0.84 = CCC |
| DSRI: 1.11 (Receivables 21.0b/15.8b, Revenue 5.98b/4.99b) |
| GMI: 0.92 (GM 29.06% / 31.74%) |
| AQI: 1.98 (AQ_t 0.97 / AQ_t-1 0.49) |
| SGI: 1.20 (Revenue 5.98b / 4.99b) |
| TATA: -0.04 (NI 418.0m - CFO 4.70b) / TA 104b) |
| Beneish M = -2.30 (Cap -4..+1) = BBB |
As of October 21, 2026, the stock is trading at USD 20.14 with a total of 724,432 shares traded. Over the past week, the price has changed by +5.50%, over one month by -11.90%, over three months by -33.89% and over the past year by -28.98%.
Current recommended Stop Loss: 19.00 (which is 5.7% or 1.5 ATR below the current price).
F&G Annuities & Life has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold FG.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24 | 19.2% |
P/E Trailing = 6.4587
P/E Forward = 4.8638
P/S = 0.4224
P/B = 0.6162
Revenue TTM = 5.98b USD
EBIT TTM = 686.0m USD
EBITDA TTM = 1.39b USD
Long Term Debt = 2.24b USD (from longTermDebt, last quarter)
Short Term Debt = 364.0m USD (from shortTermDebt, two quarters ago)
Debt = 2.25b USD (from shortLongTermDebtTotal, last quarter) + Leases 11.0m
Net Debt = -398.0m USD (calculated: Debt 2.25b - CCE 2.65b)
Enterprise Value = 2.16b USD (2.56b + Debt 2.25b - CCE 2.65b)
Interest Coverage Ratio = 4.16 (Ebit TTM 686.0m / Interest Expense TTM 165.0m)
EV/FCF = 0.46x (Enterprise Value 2.16b / FCF TTM 4.69b)
FCF Yield = 216.6% (FCF TTM 4.69b / Enterprise Value 2.16b)
FCF Margin = 78.46% (FCF TTM 4.69b / Revenue TTM 5.98b)
Net Margin = 6.99% (Net Income TTM 418.0m / Revenue TTM 5.98b)
Gross Margin = 31.74% ((Revenue TTM 5.98b - Cost of Revenue TTM 4.08b) / Revenue TTM)
Gross Margin QoQ = 19.14% (prev 59.22%)
Tobins Q-Ratio = 0.02 (Enterprise Value 2.16b / Total Assets 104b)
Interest Expense / Debt = 7.33% (Interest Expense 165.0m / Debt 2.25b)
Taxrate = 18.62% (97.0m / 521.0m)
NOPAT = 558.3m (EBIT 686.0m * (1 - 18.62%))
Current Ratio = 0.14 (Total Current Assets 2.65b / Total Current Liabilities 18.7b)
Debt / Equity = 0.49 (Debt 2.25b / totalStockholderEquity, last quarter 4.61b)
Debt / EBITDA = -0.29 (Net Debt -398.0m / EBITDA 1.39b)
Debt / FCF = -0.08 (Net Debt -398.0m / FCF TTM 4.69b)
Total Stockholder Equity = 4.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.43% (Net Income 418.0m / Total Assets 104b)
RoE = 8.86% (Net Income TTM 418.0m / Total Stockholder Equity 4.72b)
RoCE = 9.86% (EBIT 686.0m / Capital Employed (Equity 4.72b + L.T.Debt 2.24b))
RoIC = 0.56% (NOPAT 558.3m / Invested Capital 100b)
WACC = 6.22% (E(2.56b)/V(4.81b) * Re(6.44%) + D(2.25b)/V(4.81b) * Rd(7.33%) * (1-Tc(0.19)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.64 | Cagr: 0.0%
[DCF] Terminal Value 73.10% ; FCFF base≈5.20b ; Y1≈4.56b ; Y5≈3.68b
[DCF] Fair Price = 454.6 (EV 59.1b - Net Debt -398.0m = Equity 59.5b / Shares 130.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 58.48 | EPS CAGR: 9.73% | SUE: -0.63 | # QB: 0
Revenue Correlation: 78.68 | Revenue CAGR: 14.74% | SUE: 1.31 | # QB: 4
EPS current Quarter (2026-09-30): EPS=0.66 | Chg30d=-19.68% | Revisions=-40% | Analysts=2
EPS current Year (2026-12-31): EPS=2.91 | Chg30d=-9.28% | Revisions=-40% | GrowthEPS=-20.1% | GrowthRev=-47.8%
EPS next Year (2027-12-31): EPS=4.63 | Chg30d=-4.53% | Revisions=-25% | GrowthEPS=+59.2% | GrowthRev=+11.6%
[Analyst] Revisions Ratio: -62% (up=0, down=5)